Melanoma: Understanding Why Some Skin Cancers Are So Dangerous

By Insight Swarm Research Team, Medical Advisor: Nikhil Joshi, MD, FRCPC

Updated April 2026 | Medical Advisor: Nikhil Joshi, MD, FRCPC

Melanoma: Understanding Why Some Skin Cancers Are So Dangerous

Most skin cancers are, relatively speaking, manageable problems. They grow slowly, they stay put, and they're almost always curable when caught. But melanoma is different. Melanoma is the one that keeps oncologists up at night — not because it's the most common skin cancer (it isn't), but because of its remarkable ability to spread throughout the body, its cleverness at hiding from the immune system, and its capacity to lie dormant for years before reappearing somewhere unexpected.

To understand why melanoma behaves so differently, you need to understand the cell it comes from. And that story starts with sunlight, DNA, and a special type of cell that was literally born to travel.

Sunburn: The Visible Evidence of DNA Destruction

Let's start with something everyone has experienced: sunburn. Most people think of sunburn as skin damage — inflammation, redness, peeling. And it is. But what's actually happening at the molecular level is far more dramatic. Sunburn is the visible evidence that ultraviolet radiation has been smashing into your DNA.

Your DNA is essentially a set of instructions written in a four-letter alphabet. Ultraviolet light — specifically UVB radiation — has enough energy to physically damage these letters. It causes adjacent letters in the DNA sequence to fuse together, creating what scientists call pyrimidine dimers. Imagine a book where random pairs of letters have been glued together — you can no longer read those words correctly.

Now, your cells have a remarkable DNA repair crew. Enzymes patrol the DNA constantly, looking for this kind of damage. When they find fused letters, they cut out the damaged section and rebuild it using the opposite strand as a template. It's like having a backup copy of every page. Most of the time, this repair works perfectly.

But sometimes the repair crew misses a spot. Or the damage happens faster than the crew can fix it — which is exactly what happens during intense sun exposure. When a cell tries to copy damaged DNA during division, the copying machinery has to guess what the original letters were. Sometimes it guesses wrong. That wrong guess is a mutation. And if that mutation happens in a gene that controls cell growth, you've taken the first step toward cancer.

The redness and pain of sunburn isn't the damage itself — it's your body's inflammatory response to the damage. The peeling skin a few days later? That's your body killing off the most heavily damaged cells and replacing them. It's a safety mechanism. But any surviving cells that carry unrepaired mutations continue living, carrying those errors forward into every future copy.

Melanocytes: The Cells Born to Travel

Here's where melanoma's story diverges from other skin cancers, and it starts with the cell of origin.

Your skin has several types of cells. The most common are keratinocytes — the workhorses that form the outer barrier. When these cells become cancerous, you get basal cell or squamous cell carcinomas. These are the "common" skin cancers, and they almost never spread to other parts of the body. They're homebodies. They stay where they are.

But scattered among the keratinocytes are much rarer cells called melanocytes. These are the cells that produce melanin — the pigment that gives skin its color and provides some protection against UV radiation. When you tan, that's your melanocytes ramping up melanin production in response to UV exposure, like workers rolling out a protective tarp.

Here's the critical detail: melanocytes are not ordinary, stay-in-place cells. They originate from something called the neural crest — a structure in the developing embryo that also gives rise to nerve cells and other cell types that migrate long distances through the body during development. Before you were born, your melanocytes traveled from the neural crest to their final positions throughout your skin. They were literally designed to migrate.

This migratory heritage is built into their DNA. Melanocytes carry an active toolkit of genes for detaching from neighbors, moving through tissue, and establishing themselves in new locations. Normal melanocytes keep these migration genes tightly controlled in adult life. But when a melanocyte becomes cancerous, these ancient migration programs can reactivate. The cell remembers how to travel.

This is why melanoma is so much more dangerous than other skin cancers. It's not that melanoma cells are tougher or grow faster — many don't. It's that they come from a cell type that is fundamentally equipped for mobility. Other skin cancer cells trying to spread are like office workers trying to climb a mountain — they don't have the gear. Melanoma cells are experienced mountaineers.

The BRAF Switch: A Stuck Growth Signal

About half of all melanomas carry a specific mutation in a gene called BRAF. To understand what this means, picture a relay race inside the cell.

When a growth signal arrives at the cell surface, it triggers a chain of molecular messengers inside the cell, each one activating the next — like a line of dominoes. BRAF is one of the dominoes in this chain, part of what scientists call the MAP kinase pathway. In a normal cell, BRAF sits quietly until it receives a signal from the domino before it. It activates, passes the message along, and then goes back to sleep.

The most common BRAF mutation in melanoma — called V600E — is like gluing one of these dominoes in the upright position. It's always "on," always sending a growth signal, regardless of whether any upstream message arrived. The cell is receiving a constant, screaming instruction to divide, even when there's no reason to.

This single mutation isn't enough to cause melanoma by itself. Remember, cancer requires multiple broken systems. But a stuck-on BRAF signal is a powerful first step — it provides the relentless growth pressure that increases the chances of additional mutations accumulating.

Understanding BRAF matters because it represents a specific, targetable vulnerability. If the cancer is driven by a stuck BRAF switch, therapies that block that switch can slow or stop growth — at least temporarily. It's like knowing exactly which circuit breaker is jammed and being able to flip it off.

The Immune System Paradox: Melanoma Is Both Visible and Invisible

Melanoma has one of the most fascinating relationships with the immune system of any cancer. On one hand, melanoma is highly "immunogenic" — meaning it produces a lot of abnormal proteins on its cell surface that the immune system can potentially recognize. It's like a burglar wearing a bright neon jacket. It should be easy to spot.

And indeed, the immune system does recognize melanoma. There are well-documented cases of melanomas spontaneously regressing — the immune system mounting a successful attack and destroying the tumor without any medical intervention. Primary melanoma tumors are often surrounded by immune cells that are clearly trying to attack them. The body knows something is wrong.

So why does melanoma ever succeed? Because melanoma cells are extraordinarily clever at immune evasion — the art of being visible but untouchable.

The primary trick melanoma uses involves a molecular handshake called the PD-1/PD-L1 checkpoint. Here's how it works: your killer T cells (the immune system's assassins) patrol the body looking for abnormal cells. When they find a suspicious cell, they check for a "don't kill me" signal before attacking. Normal cells display this signal legitimately — it prevents the immune system from attacking healthy tissue.

Melanoma cells learn to fake this signal. They put PD-L1 on their surface — the molecular equivalent of a stolen police uniform. When killer T cells approach and check for the signal, they see it and back off. The cancer is hiding in plain sight.

Melanoma also corrupts the environment around it. It recruits regulatory T cells — immune cells whose job is to calm down immune responses — and positions them like bodyguards around the tumor. It releases chemical signals that create a suppressive fog, turning the local immune environment from hostile to tolerant. The immune system can see the cancer, but it's been convinced not to attack.

This understanding has revolutionized melanoma treatment. Immune checkpoint inhibitor drugs work by blocking the fake "don't kill me" handshake. They essentially strip off the stolen police uniform, allowing the immune system to recognize and attack the melanoma cells it was already primed to destroy. For a cancer that was once considered almost untreatable once it spread, this approach has been transformative.

Why Melanoma Can Hide for Years

Like certain breast cancers, melanoma has a disturbing ability to lie dormant. A person can have a melanoma successfully removed and then, years or even a decade later, develop metastatic disease. Where were those cells hiding all that time?

The answer lies in the concept of tumor dormancy, and melanoma is particularly good at it. After the primary tumor is removed, scattered melanoma cells may already be lodging in distant organs — the lungs, liver, brain, or bone. But instead of immediately growing into new tumors, they enter a quiescent state. They stop dividing. They hunker down.

In this dormant state, they're incredibly difficult to detect. They're not growing, so they don't form visible masses on scans. They're metabolically quiet, so they don't produce the signals that many detection methods look for. They're essentially invisible.

What triggers them to wake up remains one of the most important questions in melanoma research. Changes in the local immune environment, inflammation, physical tissue changes, and other factors have all been proposed. Understanding dormancy — and finding ways to either keep cells permanently dormant or eliminate them while they're sleeping — is a major focus of current research.

Why Early Detection Matters So Much

Everything we've discussed — the migratory heritage, the immune evasion, the capacity for dormancy — explains why melanoma is treated with such urgency compared to other skin cancers. The window between a melanoma that's completely curable (still confined to the top layer of skin) and one that has potentially spread is measured in millimeters.

The thickness of the melanoma at the time of removal — measured in fractions of a millimeter — is one of the strongest predictors of outcome. A melanoma less than one millimeter thick has an excellent prognosis. Once it grows deeper, reaching blood vessels and lymphatic channels, the probability of microscopic spread increases rapidly.

This is why dermatologists emphasize regular skin checks and why any changing mole should be evaluated promptly. It's not about worry — it's about biology. The difference between catching a melanoma at 0.5 millimeters versus 2 millimeters can be profound.

What This Means for You as a Caregiver

If you're caring for someone with melanoma, understanding the biology helps in several ways. First, it explains why the medical team may recommend immune-based approaches — the immune system already wants to fight melanoma; it just needs the handcuffs removed. Second, it explains why BRAF testing matters — about half of melanomas have a specific, targetable vulnerability. Third, it explains why long-term monitoring is essential — melanoma's capacity for dormancy means vigilance continues for years.

Melanoma is a cancer that has taught scientists more about how the immune system interacts with cancer than almost any other type. That knowledge has led to breakthroughs that are now being applied across many cancer types. Understanding the biology doesn't just help you navigate the current situation — it connects you to one of the most rapidly evolving areas in all of cancer research.

Questions to Bring to Your Doctor

Understanding the biology gives you better questions. Here are ones worth asking:

Our 14 AI research agents can analyze your specific situation across the full landscape of published research — finding connections your medical team may not have time to search for. It takes five minutes.

Frequently Asked Questions

Why is melanoma more dangerous than other skin cancers?

Melanoma arises from melanocytes — cells that originate from the neural crest during embryonic development and are inherently designed to migrate through the body. Unlike keratinocytes (which produce the more common basal cell and squamous cell cancers), melanocytes carry an active genetic toolkit for detachment, movement, and colonization of new locations. When a melanocyte becomes cancerous, these dormant migration programs can reactivate, giving melanoma a natural ability to spread that other skin cancers simply don't have.

What does BRAF mutation mean in melanoma?

BRAF is a gene that encodes a protein in the cell's growth signaling pathway. About half of all melanomas carry a mutation (most commonly V600E) that makes this protein permanently active — like a growth switch stuck in the 'on' position. The cell receives a constant signal to divide regardless of whether external growth signals are present. This specific mutation can be detected through tumor testing and represents a targetable vulnerability.

How does UV radiation cause melanoma?

Ultraviolet radiation physically damages DNA by fusing adjacent molecular letters together. While cells have repair enzymes that fix most damage, some errors escape repair — especially during intense sun exposure when damage outpaces the repair crew. When cells copy damaged DNA during division, they may introduce permanent mutations. If those mutations accumulate in genes controlling growth, cell death, or migration in a melanocyte, the path toward melanoma begins. Sunburn is the visible evidence of this DNA destruction.

Why does melanoma sometimes respond well to immunotherapy?

Melanoma is highly 'immunogenic' — it produces many abnormal proteins that the immune system can recognize. The immune system often actively tries to attack melanoma, which is why these tumors are frequently surrounded by immune cells. However, melanoma cells learn to display fake 'don't attack me' signals (PD-L1) that trick the immune system into standing down. Immune checkpoint inhibitors block this fake signal, allowing the immune system to resume its attack on cancer cells it was already primed to destroy.

Can melanoma come back years after it was removed?

Yes. Melanoma cells can enter a dormant state in distant organs — alive but not dividing, essentially invisible to scans and detection methods. These dormant cells can persist for years or even a decade before something triggers them to begin growing again. This is why long-term monitoring after melanoma treatment is essential, and why any new symptoms — even years later — should be reported to the medical team promptly.